Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,031,957
-
Share change
-
-169,008
-
Total reported value
-
$103,640,000
-
Price per share
-
$4.50
-
Number of holders
-
32
-
Value change
-
-$835,150
-
Number of buys
-
10
-
Number of sells
-
22
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q4 2021
As of 31 Dec 2021,
SATSUMA PHARMACEUTICALS INC - COM (STSA) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,031,957 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., COMMODORE CAPITAL LP, NEA Management Company, LLC, TPG GP A, LLC, SAMLYN CAPITAL, LLC, Vivo Capital, LLC, CITADEL ADVISORS LLC, Ghost Tree Capital, LLC, AMERIPRISE FINANCIAL INC, and VANGUARD GROUP INC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.